Introduction 33
Biologically active peptides are specific fragments of proteins with 2 to 20 amino acids 34 that have desirable biological activities ( 
Fourier transform infrared (FT-IR) analysis of the samples 151
The hydrolysate, both in its free form and microencapsulated within the biopolymers, 152 was dispersed in spectroscopic grade potassium bromide (KBr). A pellet was then 153
formed by compressing the sample at ca. 150 MPa and FT-IR spectra were collected in 154 transmission mode using a Bruker FT-IR Tensor 37 equipment (Rheinstetten, 155 Germany). The spectra were obtained by averaging 10 scans at 1 cm phase, the dispersions were mixed with SSF (50:50 v/v) and incubated at 37 ºC for 2 165 min in a shaking incubator at 150 rpm. In the gastric phase, the oral digest was mixed 166 with SGF (50:50 v/v) and porcine pepsin (2000 U/mL), and incubated at 37 ºC for 2 h in 167 a shaking incubator at 150 rpm). In the duodenal phase, the gastric digest was mixed 168 with SIF (50:50 v/v), porcine bile extract (10 mM) and porcine pancreatin (100 U/mL of 169 trypsin activity), and incubated at 37 ºC for 2 h as described above. The pH was initially 170 adjusted to 7, 3, and 7 in the oral, gastric and duodenal phases, respectively. After the 171 duodenal phase, the protease inhibitor Pefabloc ® (1 mM) was added and the digests 172
were snap-frozen in liquid nitrogen for subsequent lyophilisation. 173
Freeze-dried samples were re-suspended in 10 mL of milliQ water and centrifuged for 174 20 min at 1795 g and 4 ºC. The supernatant was then ultracentrifuged using 175
Centriprep® Ultracel® YM-3 centrifugal filter units (Millipore, Cork, Ireland) with a 176 molecular weight cut-off of 3 kDa. The ultracentrifugation was carried out at 3000 g 177 and 4 ºC in three steps of 95 min, 35 min and 10 min, respectively, according to the 178 supplier's instructions. The ultrafiltrates were freeze-dried for storage and re-dissolved 179 in milliQ water prior to HPLC-MS/MS analysis. 180
Samples of the hydrolysate-loaded microcapsules (non-digested) were suspended in 181 acetic acid (20% v/v) under vigorous agitation to dissolve the encapsulation matrices, 182 and subsequently ultrafiltered following the same procedure described above for the 183 digests in order to assess the effective release of the peptides from their encapsulation 184 matrices. 185 to specific trypsin sites after Arg and Lys residues, but also peptides with Leu, Phe, Glu 231
and Tyr at the C-terminal position were found. A food-grade trypsin was used in this 232 study, which explains the broad specificity, since this enzyme preparation has 233 chymotrypsin activity. Table 1 in the hydrolysate-loaded chitosan capsules. However, certain bands of the 290 encapsulated hydrolysate shifted to higher or lower wavenumbers as compared to both 291 components of the particles. Although it is difficult to draw conclusions given the 292 overlapping of most spectral bands and the highly coupled modes in the Amide I and II 293 regions, interactions between the peptides from the hydrolysate and the encapsulation 294 matrices seem to have taken place during the encapsulation process, as inferred from the 295 spectral changes in this area observed in the hybrid capsules (see insets in Fig. 2a and  296 2b). These interactions could, in fact, explain why certain peptides were not detected 297 after dissolving the capsules (Table 1) 
Identification of peptides after encapsulation 310
In order to corroborate the effective encapsulation of the hydrolysate within the two 311 biopolymer matrices, the loaded chitosan and gelatin capsules were subjected to 312 extraction in acidic conditions, dissolving the encapsulation matrices and thus favouring 313 the release of the peptides. The comparison of the total ion current (TIC) 314 chromatograms obtained by HPLC-MS/MS showed little differences indicating an 315 effective release of the hydrolysate from the capsules (Fig. 3) . Most of the peptides 316 present in the initial hydrolysate were identified, which demonstrated that the 317 encapsulation procedure did not affect the peptide profile to a great extent (Table 1) . 318
Even then, 13 peptides out of 58 from the hydrolysate could not be identified after 319 capsule disruption, probably due to interactions of the peptides with the encapsulation 320 matrices as suggested by the FT-IR results. On the other hand, some peptides were 321 newly found after dissolution, 11 in the case of chitosan capsules and 9 in the case of 322 gelatin capsules, 4 of which were common sequences. Peptide-matrix interactions might 323 have affected peptide identification, specially taking into account that the purification of 324 the samples prior to HPLC-MS/MS analysis included an ultrafiltration step to remove 325 high molecular weight molecules, probably affecting the recovery of the peptides 326 interacting with the matrices. Despite the observed exceptions, it was confirmed that the 327 peptides in the hydrolysate could be released from the microcapsules under suitable 328 Simulated digestion of the free hydrolysate resulted in a remarkable change in the 345 identified peptides. Their number was reduced by half in the case of β-Lg fragments 346 (Fig. 4a, b) . In the case of α-La, with a lower number of peptides, a similar tendency 347 was found. Only two complete sequences from β-Lg (fragments 108-113, ENSAEP and 348 110-115, SAEPEQ) and one from α-La (fragment 63-68, DDQNPH) were resistant to 349 the simulated gastrointestinal digestion. In most cases, peptides identified in the digesta 350 corresponded to fragments from those found in the non-digested sample. The lower 351 number of peptides can be attributed to their degradation to form di-or tri-peptides or 352 free amino acids. Besides, the digesta contained enzyme autolytic fragments and bile 353 salts, giving rise to a much more complex matrix which complicated peptide detection. 354
In the digesta from the hydrolysate-loaded chitosan microparticles, 23 peptides could be 355 identified, 17 of which were similar to those found in the digested free hydrolysate (Fig.  356 4b, c). On the other hand, the digesta from the hydrolysate-loaded gelatin capsules 357 produced a very complex chromatogram where only two peptides from the whey 358 proteins could be identified. The proteinaceous origin of the encapsulation matrix, 359 which was also digested into peptides by the enzymes added during the assay was most 360 probably causing this interference. After analysis of the fermented products, five peptides were protected by encapsulation, 388 since they were present in the hydrolysate prior fermentation but not in the yogurt 389 enriched with free hydrolysate (Fig. 5) 
